Related to Creating and Using Plastic Antibodies

• NIPTE Receives $35M from FDA to Reform Drug Manufacturing Standards
  
• Chemokine Receptor-Targeting siRNA Nanoparticles Used to Reduce Damage in Multiple Disease Models
  
• QuantuMDx Licenses Nanosys’ Nanostructures for Use in Handheld Diagnostic Platform
  
• WuXi Takes Over Antibody and Research Reagents Firm Abgent
  
• GeoVax and Vivalis Sign Deal for the Biomanufacture of MVA HIV Vaccine in EB66 Cells
  
• Lonza to Manufacture Genmab’s Tissue Factor-Targeting Antibody-Drug Conjugate
  
• Inhibrx Taps ProBioGen to Boost ADCC Potency of Antibody Candidates
  
• Selecta and Bind Each Obtain $47.25M from Russian Federation Fund
  
• Repligen Buys Novozymes Biopharma Sweden for $22.7M
  
• GSK Taps Alnylam’s RNAi Technology for Vaccine Production
  
• Nanolipid Vesicle Platform Developed that Uses Subattoliter Volumes for Screening Reactions
  
• Pfizer Returns Two Early-Stage Anti-TNF-Alpha Nanobodies to Ablynx
  
• Avaxia Raises $2.2M to Take Oral Antibody IBD Candidate into Clinical Trials
  
• CureVac, Sanofi Pasteur, and In-Cell-Art Collaborate on €33.1M DARPA-Supported Vaccine Program
  
• Oxyrane Raises $26.5M to Take Lead Enzyme Replacement Therapy Through Phase I/II
  
• Aveo Signs BI on as Production Partner for Clinical-Stage mAb
  
• Rainbow to Snap Up n3D’s Three-Dimensional Cell Culturing Technology
  
• GE Healthcare, M+W to Bolster Biomanufacturing in Emerging Nations
  
• Cerulean Raises $15M to Continue Phase II Trial with NSCLC Nanodrug
  
• Renova to Develop Transgenic Rabbits for Pharming’s Recombinant FVIII Program